WHOOP is First Wearable to Be Used in Phase 3 COVID-19 Vaccine Trials
August 13, 2020 | PR NewswireEstimated reading time: 2 minutes
Abu Dhabi-based G42 Healthcare has announced a volunteer healthcare management program with Boston-based wearable technology firm WHOOP. The partnership will offer volunteers participating in the world's first Phase III trials of an inactivated COVID-19 vaccine the opportunity to benefit from a 24/7 fitness and health monitor to measure key biometrics. This is the first trial of its kind to feature wearable technology and will include thousands of volunteers who are participating in the trials.
The Whoop4Humanity initiative ensures that volunteers who now join the clinical trials at ADNEC in Abu Dhabi and the Al Qarain Center in Sharjah, including those coming in for the second dose, can further enhance their participation in the trails by using the new wearable devices which will enable them to check their daily heart rate, respiratory rate, heart rate variability, sleep performance, and more.
Commenting on the new partnership, G42 Healthcare CEO Ashish Koshy said: "As a digital business, this new partnership is a logical extension of the highly-advanced AI and super computer solutions we are already using in the trials process. New volunteers will be invited to engage with the technology developed by WHOOP to enhance their individual volunteer experience and contribute to the advanced research involved in these sophisticated trials.
"We believe that giving volunteers an opportunity to use the WHOOP Strap 3.0 wearable device will reinforce their confidence in the trial by giving them the ability to check on several daily health data points. This will complement the world-class clinical expertise that the healthcare professionals in the UAE are providing to the volunteers and ensure their safety and well-being throughout the trials process."
G42 Healthcare believes that WHOOP can be a powerful tool to boost the comprehensive volunteer healthcare management program by helping thousands of vaccine volunteers to self-monitor their well-being while measuring their fitness, sleep, and recovery levels during the trials. WHOOP provides valuable insights and actionable feedback around specific markers, thus encouraging better decision making for volunteers' health and contributing to the trials' overall success.
"WHOOP is proud to partner with G42 Healthcare and participate in their innovative Phase III COVID-19 vaccine trial," said Will Ahmed, WHOOP Founder & CEO. "The continuous biometric monitoring offered by WHOOP will help volunteers evaluate any changes to their health and help researchers vastly increase their understanding of the vaccine's impact. This partnership represents the future of healthcare: using continuous monitoring and artificial intelligence to better understand the effect of drugs, vaccines, and other treatments."
WHOOP uniquely blends hardware, software, and industry-leading accurate measurements to help people sharpen the edges of performance, create impactful behavior change and a new set of positive individual habits, and empower them to optimize all facets of life.
The trials began in Abu Dhabi on 16th July and are being managed by G4 Healthcare in partnership with the Department of Health - Abu Dhabi, the UAE Ministry of Health and Prevention (MOHAP) and Abu Dhabi Health Services Company (SEHA). They are being conducted following the international guidelines stipulated by the World Health Organization (WHO) and the United States Food & Drug Administration (USFDA).
The Phase III clinical trials follow the success of the Phase I and Phase II trials conducted by Sinopharm in China, which resulted in 100% of the volunteers generating antibodies to SARS-CoV-2, the virus that causes COVID-19, after two doses in 28 days. The Phase III trials are open to individual volunteers aged between 18 and 60 living in the UAE and Bahrain and will last for six to twelve months, with the volunteers required to be available for follow ups during this time.
Suggested Items
Kimball Electronics Thailand Helps Save Lives by Hosting a Blood Drive
05/14/2024 | Kimball ElectronicsKimball Electronics Thailand employees took part in a blood donation event. The blood drive took place in the Rajapruek Building at Laem Chabang Industrial Estate Office.
EMA Webinar: Next Generation MCAD/ECAD for SOLIDWORKS
05/09/2024 | EMA Design AutomationLearn how the MCAD and ECAD experts at Hawk Ridge and EMA can help you solve your MCAD/ECAD integration challenges with this unique collaboration environment.
Real Time with… IPC APEX EXPO 2024: Alltemated Focuses on Services and Customer Relationships
05/09/2024 | Real Time with...IPC APEX EXPORachael Temple, director of marketing and sales at Alltemated, discusses the company's offerings such as outsourcing, value added services, and quick turnaround times. Rachael emphasizes the significance of fostering relationships and trust with clients, sharing a real world example where Alltemated helped a component distributor with custom tooling, and then wraps up with a look at future growth and collaborations.
Real Time with… IPC APEX EXPO 2024: The Latest Advancements in Dry Storage
04/30/2024 | Real Time with...IPC APEX EXPOEditor Marcy LaRont and Super Dry Totech's Jordan Mandel discuss the latest developments in dry storage solutions, the J standard, and the ongoing challenge of moisture management while highlighting the industry's shift toward smart solutions and the importance of seeking expert help for moisture mitigation.
It’s Only Common Sense: Seeking the Possibility of Opportunity
03/11/2024 | Dan Beaulieu -- Column: It's Only Common SenseWe are often so immersed in what we are doing that we don’t have time to lift our heads and open our eyes to the possibility of opportunity. Why is this a problem? It’s because being open to opportunities is crucial for success in sales (as it is in all of business and in). Over the years, I have found there are several ways to take advantage of opportunities. The absolute best way is to always have an open mind. Here are some ways I do that.